{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:36:52Z","timestamp":1794537412810,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900633"],"award-info":[{"award-number":["81900633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870498"],"award-info":[{"award-number":["81870498"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Our preliminary work has revealed that vitamin D receptor (VDR) activation is protective against cisplatin induced acute kidney injury (AKI). Ferroptosis was recently reported to be involved in AKI. Here in this study, we investigated the internal relation between ferroptosis and the protective effect of VDR in cisplatin induced AKI. By using ferroptosis inhibitor ferrostatin-1 and measurement of ferroptotic cell death phenotype in both in vivo and in vitro cisplatin induced AKI model, we observed the decreased blood urea nitrogen, creatinine, and tissue injury by ferrostatin-1, hence validated the essential involvement of ferroptosis in cisplatin induced AKI. VDR agonist paricalcitol could both functionally and histologically attenuate cisplatin induced AKI by decreasing lipid peroxidation (featured phenotype of ferroptosis), biomarker 4-hydroxynonenal (4HNE), and malondialdehyde (MDA), while reversing glutathione peroxidase 4 (GPX4, key regulator of ferroptosis) downregulation. VDR knockout mouse exhibited much more ferroptotic cell death and worsen kidney injury than wild type mice. And VDR deficiency remarkably decreased the expression of GPX4 under cisplatin stress in both in vivo and in vitro, further luciferase reporter gene assay showed that GPX4 were target gene of transcription factor VDR. In addition, in vitro study showed that GPX4 inhibition by siRNA largely abolished the protective effect of paricalcitol against cisplatin induced tubular cell injury. Besides, pretreatment of paricalcitol could also alleviated Erastin (an inducer of ferroptosis) induced cell death in HK-2 cell. These data suggested that ferroptosis plays an important role in cisplatin induced AKI. VDR activation can protect against cisplatin induced renal injury by inhibiting ferroptosis partly via trans-regulation of GPX4.<\/jats:p>","DOI":"10.1038\/s41419-020-2256-z","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T07:03:53Z","timestamp":1580281433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":258,"title":["VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Zhaoxin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6552-0176","authenticated-orcid":false,"given":"Shikun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-2306","authenticated-orcid":false,"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-6713","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"2256_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo, R., Kellum, J. A. & Ronco, C. Acute kidney injury. Lancet. 380, 756\u2013766 (2012).","journal-title":"Lancet"},{"key":"2256_CR2","doi-asserted-by":"publisher","first-page":"967826","DOI":"10.1155\/2014\/967826","volume":"2014","author":"A Ozkok","year":"2014","unstructured":"Ozkok, A. & Edelstein, C. L. Pathophysiology of cisplatin-induced acute kidney injury. Biomed. Res. Int. 2014, 967826 (2014).","journal-title":"Biomed. Res. Int"},{"key":"2256_CR3","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1681\/ASN.2014080741","volume":"26","author":"Y Xu","year":"2015","unstructured":"Xu, Y. et al. A role for tubular necroptosis in cisplatin-induced AKI. J. Am. Soc. Nephrol. 26, 2647\u20132658 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2256_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/0886022X.2011.647343","volume":"34","author":"VR Tristao","year":"2012","unstructured":"Tristao, V. R. et al. Nec-1 protects against nonapoptotic cell death in cisplatin-induced kidney injury. Ren. Fail. 34, 373\u2013377 (2012).","journal-title":"Ren. Fail"},{"key":"2256_CR5","doi-asserted-by":"publisher","first-page":"F1239","DOI":"10.1152\/ajprenal.00659.2011","volume":"303","author":"C Herzog","year":"2012","unstructured":"Herzog, C., Yang, C., Holmes, A. & Kaushal, G. P. zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function. Am. J. Physiol. Ren. Physiol. 303, F1239\u2013F1250 (2012).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2256_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"2256_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"2256_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1523-1755.1998.00767.x","volume":"53","author":"R Baliga","year":"1998","unstructured":"Baliga, R., Zhang, Z., Baliga, M., Ueda, N. & Shah, S. V. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 53, 394\u2013401 (1998).","journal-title":"Kidney Int"},{"key":"2256_CR9","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1172\/JCI88887","volume":"127","author":"JW Pike","year":"2017","unstructured":"Pike, J. W., Meyer, M. B., Lee, S. M., Onal, M. & Benkusky, N. A. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights. J. Clin. Invest. 127, 1146\u20131154 (2017).","journal-title":"J. Clin. Invest"},{"key":"2256_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12882-017-0576-8","volume":"18","author":"L Mansouri","year":"2017","unstructured":"Mansouri, L. et al. Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease\u2014a randomized trial. BMC Nephrol. 18, 161 (2017).","journal-title":"BMC Nephrol."},{"key":"2256_CR11","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1681\/ASN.2012040383","volume":"23","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Vitamin D receptor signaling in podocytes protects against diabetic nephropathy. J. Am. Soc. Nephrol. 23, 1977\u20131986 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2256_CR12","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3892\/etm.2017.4211","volume":"13","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. 1,25-(OH)2D3 and its analogue BXL-628 inhibit high glucose-induced activation of RhoA\/ROCK pathway in HK-2 cells. Exp. Ther. Med. 13, 1969\u20131976 (2017).","journal-title":"Exp. Ther. Med"},{"key":"2256_CR13","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1210\/jc.2016-1516","volume":"101","author":"B Yi","year":"2016","unstructured":"Yi, B. et al. Vitamin D receptor down-regulation is associated with severity of albuminuria in type 2 diabetes patients. J. Clin. Endocrinol. Metab. 101, 4395\u20134404 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2256_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.ki.5002256","volume":"72","author":"Q Wei","year":"2007","unstructured":"Wei, Q., Dong, G., Franklin, J. & Dong, Z. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int. 72, 53\u201362 (2007).","journal-title":"Kidney Int"},{"key":"2256_CR15","doi-asserted-by":"publisher","first-page":"322,","DOI":"10.1038\/s41419-018-0374-7","volume":"9","author":"Liu, J.","year":"2018","unstructured":"Liu, J. et al. Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells. Cell Death Dis. 9, 322, (2018).","journal-title":"Cell Death Dis."},{"key":"2256_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.377","volume":"8","author":"B Du","year":"2017","unstructured":"Du, B. et al. MiR-30c regulates cisplatin-induced apoptosis of renal tubular epithelial cells by targeting Bnip3L and Hspa5. Cell Death Dis. 8, e2987 (2017).","journal-title":"Cell Death Dis."},{"key":"2256_CR17","doi-asserted-by":"publisher","first-page":"F610","DOI":"10.1152\/ajprenal.00101.2003","volume":"285","author":"G Ramesh","year":"2003","unstructured":"Ramesh, G. & Reeves, W. B. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am. J. Physiol. Ren. Physiol. 285, F610\u2013F618 (2003).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2256_CR18","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","volume":"111","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A. et al. Synchronized renal tubular cell death involves ferroptosis. Proc. Natl. Acad. Sci. USA 111, 16836\u201316841 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2256_CR19","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1096\/fj.201900077R","volume":"33","author":"M Guerrero-Hue","year":"2019","unstructured":"Guerrero-Hue, M. et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J. 33, 8961\u20138975 (2019).","journal-title":"FASEB J."},{"key":"2256_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1046\/j.1523-1755.2003.00908.x","volume":"63","author":"H Liu","year":"2003","unstructured":"Liu, H. & Baliga, R. Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 63, 1687\u20131696 (2003).","journal-title":"Kidney Int"},{"key":"2256_CR21","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.2174\/0929867325666180214122352","volume":"25","author":"S Yang","year":"2018","unstructured":"Yang, S. et al. Vitamin D receptor: a novel therapeutic target for kidney diseases. Curr. Med. Chem. 25, 3256\u20133271 (2018).","journal-title":"Curr. Med. Chem."},{"key":"2256_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1308\/003588413X13629960049117","volume":"95","author":"A Azak","year":"2013","unstructured":"Azak, A. et al. Effect of novel vitamin D receptor activator paricalcitol on renal ischaemia\/reperfusion injury in rats. Ann. R. Coll. Surg. Engl. 95, 489\u2013494 (2013).","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"2256_CR23","doi-asserted-by":"publisher","first-page":"F1068","DOI":"10.1152\/ajprenal.00332.2018","volume":"316","author":"J Du","year":"2019","unstructured":"Du, J. et al. Vitamin D receptor activation protects against lipopolysaccharide-induced acute kidney injury through suppression of tubular cell apoptosis. Am. J. Physiol. Ren. Physiol. 316, F1068\u2013F1077 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2256_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/ijmy.ijmy_120_17","volume":"6","author":"MR Wahyunitisari","year":"2017","unstructured":"Wahyunitisari, M. R., Mertaniasih, N. M., Amin, M., Artama, W. T. & Koendhori, E. B. Vitamin D, cell death pathways, and tuberculosis. Int. J. Mycobacteriol. 6, 349\u2013355 (2017).","journal-title":"Int. J. Mycobacteriol"},{"key":"2256_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10157-018-1614-y","volume":"23","author":"M Hamzawy","year":"2019","unstructured":"Hamzawy, M. et al. 22-oxacalcitriol prevents acute kidney injury via inhibition of apoptosis and enhancement of autophagy. Clin. Exp. Nephrol. 23, 43\u201355 (2019).","journal-title":"Clin. Exp. Nephrol."},{"key":"2256_CR26","first-page":"9245702","volume":"2017","author":"C Cui","year":"2017","unstructured":"Cui, C. et al. Vitamin D receptor activation influences NADPH Oxidase (NOX2) Activity and protects against neurological deficits and apoptosis in a rat model of traumatic brain injury. Oxid. Med. Cell Longev. 2017, 9245702 (2017).","journal-title":"Oxid. Med. Cell Longev."},{"key":"2256_CR27","doi-asserted-by":"publisher","first-page":"109170","DOI":"10.1016\/j.biopha.2019.109170","volume":"117","author":"C Chen","year":"2019","unstructured":"Chen, C., Luo, Y., Su, Y. & Teng, L. The vitamin D receptor (VDR) protects pancreatic beta cells against Forkhead box class O1 (FOXO1)-induced mitochondrial dysfunction and cell apoptosis. Biomed. Pharmacother. 117, 109170 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"2256_CR28","first-page":"9013904","volume":"2019","author":"X Zhu","year":"2019","unstructured":"Zhu, X., Wu, S. & Guo, H. Active Vitamin D and Vitamin D receptor help prevent high glucose induced oxidative stress of renal tubular cells via AKT\/UCP2 signaling pathway. Biomed. Res. Int. 2019, 9013904 (2019).","journal-title":"Biomed. Res. Int"},{"key":"2256_CR29","first-page":"5065","volume":"8","author":"Y Ding","year":"2015","unstructured":"Ding, Y., Liao, W., Yi, Z., Xiang, W. & He, X. Cardioprotective role of vitamin D receptor in circulating endothelial cells of ApoE-deficient mice. Int J. Clin. Exp. Med. 8, 5065\u20135074 (2015).","journal-title":"Int J. Clin. Exp. Med"},{"key":"2256_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1172\/JCI111524","volume":"74","author":"MS Paller","year":"1984","unstructured":"Paller, M. S., Hoidal, J. R. & Ferris, T. F. Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest. 74, 1156\u20131164 (1984).","journal-title":"J. Clin. Invest"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2256-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:40:19Z","timestamp":1670233219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["2256"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2256-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"10 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"73"}}